Results 1 to 10 of about 2,203 (134)

3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex [PDF]

open access: yesPLoS ONE, 2022
PurposeThis study aimed at evaluating the orbital anatomy of patients concerning the relevance of orbital anatomy in the etiology of EO (endocrine orbitopathy) and exophthalmos utilizing a novel approach regarding three-dimensional measurements ...
Konstantin Volker Hierl, Ina Sterker
exaly   +5 more sources

Consideration of specific key points improves outcome of decompression treatment in patients with endocrine orbitopathy: pre-/post-OP comparison and biomechanical simulation [PDF]

open access: yesEuropean Journal of Medical Research, 2022
Endocrine orbitopathy is typically treated by resecting orbital walls. This procedure reduces intraorbital pressure by releasing intraorbital tissue, effectively alleviating the symptoms.
Matthias Krause   +7 more
doaj   +2 more sources

Eyes wide shut: necessity and effect of adjunctive procedures after decompression surgery in patients with endocrine orbitopathy [PDF]

open access: yesHead & Face Medicine, 2021
Background Orbital decompression surgery is frequently the last therapeutic measure in the surgical treatment of endocrine orbitopathy (EO). Additional rehabilitative and corrective surgical treatments are often used to improve the resulting eyelid ...
Matthias Krause   +7 more
doaj   +2 more sources

Quality of life and occupational disability in endocrine orbitopathy. [PDF]

open access: yesDtsch Arztebl Int, 2009
In endocrine orbitopathy (EO), disfiguring proptosis and diplopia impair patients' quality of life both at home and at work.From late 2006 to the beginning of 2008, 250 outpatients in an interdisciplinary thyroid and eye clinic filled out a questionnaire about their quality of life, occupational disability, and use of psychotherapy.
Ponto KA   +5 more
europepmc   +4 more sources

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy

open access: yesFrontiers in Endocrinology, 2022
BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi   +16 more
doaj   +1 more source

On Endocrine Orbitopathy

open access: yesOphthalmic Research, 2009
From previous clinical and experimental observations with animals it is clear that the exophthalmos producing factor (EPF) is not the only factor which is responsible for endocrine orbitopathy. Therefore, a study of the effect of ACTH, cortisol, adrenaline, testosterone, oestradiol and oestriol on experimental exophthalmos in fish was made. Preliminary
M.U. Dardenne   +3 more
openaire   +2 more sources

The role of hormonal imbalance in the development of autoimmune dacryoadenitis in endocrine orbitopathy

open access: yesOftalʹmologiâ, 2014
The authors analyzed the hormonal profile of patients with Graves’ disease and endocrine orbitopathy with or without autoimmune dacryoadenitis.
V. G. Likhvantseva   +4 more
doaj   +3 more sources

Thyroid disease‐specific quality of life questionnaires ‐ A systematic review

open access: yesEndocrinology, Diabetes & Metabolism, 2022
Introduction Thyroid diseases are very common and rarely life‐threatening. One of the main therapeutic goals is an improvement in quality of life, making it important to measure in clinical and research settings.
Verena Uslar   +3 more
doaj   +1 more source

Radiological features of endocrine orbitopathy involving lacrimal gland

open access: yesOftalʹmologiâ, 2014
According to orbit computer tomography, lacrimal gland is involved in autoimmune process in 26.8% of patients with Graves’ orbitopathy. A short orbit is a predisposing factor of the lacrimal gland (LG) involvement in the autoimmune process.
V. G. Likhvantseva   +5 more
doaj   +3 more sources

Association of Other Autoimmune Diseases With Thyroid Eye Disease

open access: yesFrontiers in Endocrinology, 2021
BackgroundThyroid eye disease (TED) is a potentially disfiguring and sight-threatening autoimmune (AI) orbitopathy, affecting up to 400,000 people in the UK. There are no accurate early predictors of TED severity. Although polyautoimmunity has been shown
Mary Kelada   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy